Clinical Nephrology » Iron sucrose in treatment of anemia in chronic kidney disease – original and generic drugs: what are the guidelines in drug choose?

Iron sucrose in treatment of anemia in chronic kidney disease – original and generic drugs: what are the guidelines in drug choose?

Yu.S. Milovanov, L.Yu. Milovanova, I.A. Dobrsmislov
State Budgetary Educational Institution of High Professional Education “First Moscow State Medical University n.a. I.M. Sechenov” Ministry of Health and Social Development of Russian Federation, Moscow

Results of comparison of efficiency and safety original and generichesky copies of a preparation of iron (III) hydroxide of a saccharose complex are given in anemia treatment at a chronic illness of kidneys.

Keywords: III

About the Autors

Milovanov Yu.S. – nephrology department leading research associate at Urology, Nephrology and Reproductive health Scientific- Research Institute and associate professor at nephrology and hemodialysis department at faculty of post diploma professional medical education at State Budgetary Educational Institution of High Professional Education “First Moscow State Medical University n.a. I.M. Sechenov” Ministry of Health and Social Development of Russian Federation. Ph.D.;
mail: yurimilovanov@yandex.ru;
Milovanova L. Yu. - leading research associate at Urology, Nephrology and Reproductive health Scientific- Research Institute at State Budgetary Educational Institution of High Professional Education “First Moscow State Medical University n.a. I.M. Sechenov” Ministry of Health and Social Development of Russian Federation. Ph.D.;
Dobrosmislov I.A. – head of renal dialyzer department at nephrology, internal and professional diseases clinic n.a. E.M. Tareev University clinical hospital #3 at State Budgetary Educational Institution of High Professional Education “First Moscow State Medical University n.a. I.M. Sechenov” Ministry of Health and Social Development of Russian Federat

Back to Content